对比剂肾病的研究进展
Published in Zhonghua xiandai huli zazhi • Jul 16, 2012
NobleIDNI8P79W75R61S35
Authors:,,
刘文娟
沈莹
夏勇
Abstract
随着影像诊断和介入治疗的迅速发展,特别是经皮冠状动脉介入术(percutaneous coronary intervention,PCI)中对比剂应用的日益增多,对比剂肾病(contrast induced nephropathy,CIN)发生率随之增加.在药物所致的医院获得性急性肾衰竭常见病因中,对比剂是仅次于氨基苷类抗生素居第2位[1]. 关键词：肾病;护理;对比剂;预防;综述文献
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!